Rhyme Organics And Chemicals Private Limited

We are manufacturer and exporter of Carglumic Acid API.

Carglumic acid API is an orphan drug, marketed by Orphan Europe under the trade name Carbaglu. Carglumic acid is used for the treatment of hyperammonaemia in patients with N-acetylglutamate synthase deficiency. The initial daily dose ranges from 100 to 250 mg/kg, adjusted thereafter to maintain normal plasma levels of ammonia.

The US FDA approved it for treatment of hyperammonaemia on March 18, 2010. Orphan Drug exclusivity expired on March 18, 2017

We are manufacturer and exporter of Clarithromycin API.

Clarithromycin, sold under the brand name Biaxin among others, is anantibiotic used to treat various bacterial infections. This includes strep throat, pneumonia, skin infections, H. pylori infection, and Lyme disease, among others. Clarithromycin can be taken by mouth as a pill or liquid.Common side effects include nausea, vomiting, headaches, and diarrhea.^[1] Severe allergic reactions are rare. Liver problems have been reported. It may cause harm if taken during pregnancy. It is in the macrolide class and works by decreasing protein production of some bacteria.

for further information

Function: Mainly used for breathing system, skin and eye allergic diseases 

Specification:

We are manufacturer and exporter of ChloramphenicolAPI.

Chloramphenicol API is an antibiotic useful for the treatment of a number of bacterial infections. This includes use as an eye ointment to treat conjunctivitis. By mouth or by injection into a vein, it is used to treat meningitis, plague, cholera, and typhoid fever

We are manufacturer and exporter of Carprofen API.

Carprofen API, marketed under many brand names worldwide, is a nonsteroidal anti-inflammatory drug (NSAID) that veterinarians prescribe as a supportive treatment for various conditions in animals. It provides day-to-day treatment for pain and inflammation from various kinds of joint pain as well as post-operative pain. Carprofen reduces inflammation by inhibition of COX-1 and COX-2; its specificity for COX-2 varies from species to species

We are manufacturer and exporter of Cefalexin API.

Cefalexin API, also spelled cephalexin, is an antibiotic that can treat a number of bacterial infections. It kills gram-positiveand some gram-negative bacteria by disrupting the growth of the bacterial cell wall. Cefalexin is a beta-lactam antibioticwithin the class of first-generation cephalosporins. It works similarly to other agents within this class, including intravenous cefazolin, but can be taken by mouth.

Cefalexin can treat certain bacterial infections, including those of the middle ear, bone and joint, skin, and urinary tract. It may also be used for certain types of pneumonia, strep throat, and to prevent bacterial endocarditis. Cefalexin is not effective against infections caused by methicillin-resistant Staphylococcus aureus (MRSA), Enterococcus, or Pseudomonas. Like other antibiotics, cefalexin cannot treat viral infections, such as the flu, common cold or acute bronchitis. Cefalexin can be used in those who have mild or moderate allergies to penicillin.However, it is not recommended in those with severe penicillin allergies.

We are manufacturer and exporter of clove oil.

Oil of clove, also known as clove oil, is an essential oil extracted from the clove plant, Syzygium aromaticum. It has the CAS number 8000-34-8.Clove is often found in the aromatherapy section of health food stores, and is used in the flavoring of some medicines. Madagascar and Indonesia are the main producers of clove oil.Clove oil has been promoted as having a wide range of health effects, but there is insufficient medical evidence to support general claims for its use as a therapeutic.

We are manufacturer and exporter of Canagliflozin API.

Canagliflozin API (trade name Invokana or Sulisent) is a medication used for the treatment of type 2 diabetes. It is of the gliflozin class or subtype 2 sodium-glucose transport (SGLT-2) inhibitors class.This mechanism is associated with a low risk of hypoglycaemia (too low blood glucose) compared to sulfonylureaderivatives and insulin. In 2017, the FDA concluded that canagliflozin causes an increased risk of leg and foot amputations. The FDA began requiring a Boxed Warning to be added to the canagliflozin drug labels to describe this risk.

Canagliflozin is an inhibitor of subtype 2 sodium-glucose transport proteins (SGLT2), which is responsible for at least 90% of renal glucose reabsorption (SGLT1 being responsible for the remaining 10%). Blocking this transporter causes up to 119 grams of blood glucose per day to be eliminated through the urine. It was developed by Mitsubishi Tanabe Pharmaand is marketed under license by Janssen, a division of Johnson & Johnson.

We are manufacturer and exporter of Carboplatin API.

It is an organoplatinum compound that possesses antineoplastic activity. We have attained strong market goodwill as a trusted organization engaged in offering Carboplatin . This drug is used for the initial treatment of advanced ovarian carcinoma. It is also indicated for the palliative treatment